// App-Quantinova.ai

435.0 : Outcomes and characteristics of patients receiving second-line therapy for advanced pancreatic cancer.

Researchers

Presenter

  • Erica S Tsang

Principal Investigators

  • Hui-Li Wong

  • Ying Wang

  • Daniel John Renouf

  • Winson Y. Cheung

  • Howard John Lim

  • Sharlene Gill

  • Jonathan M. Loree

  • Hagen F. Kennecke

Medical Centers

  • BC Cancer Agency, Vancouver, BC, Canada

  • Walter and Eliza Hall Institute of Medical Research, Parkville, Australia

  • The University of British Columbia, Vancouver, BC, Canada

  • Vancouver Prostate Centre, Vancouver, BC, Canada

  • University of Calgary Tom Baker Cancer Centre, Calgary, AB, Canada

  • Virginia Mason Medical Center, Seattle, WA

Locations

  • Canada

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Adenomatous Polyposis Coli

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved